Seoul, South Korea

Han Yong Yoo

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Yungjin Pharmaceutical Co., Ltd.. Active years: 1999-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Han Yong Yoo. Retrieved from https://idiyas.com/inventor/han-yong-yoo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 12.5

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Han Yong Yoo

Introduction

Han Yong Yoo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Yoo has established himself as a key figure in the development of new chemical compounds.

Latest Patents

Among his latest patents are the Heterocycle-fused thiazole derivatives and the 4-amino-3-acylnaphthyridine derivatives. These inventions showcase his expertise in creating novel compounds that have potential applications in various therapeutic areas.

Career Highlights

Yoo has worked with notable companies such as Yungjin Pharmaceutical Co., Ltd. and Dae Pil Kang. His experience in these organizations has allowed him to refine his skills and contribute to important projects in the pharmaceutical industry.

Collaborations

Throughout his career, Han Yong Yoo has collaborated with talented individuals, including Dae Pil Kang and Sung Gyu Kim. These partnerships have fostered a creative environment that has led to the successful development of innovative solutions.

Conclusion

Han Yong Yoo's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in chemical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…